Kolon Life Science Inc (102940) - Total Liabilities

Latest as of September 2025: ₩295.72 Billion KRW ≈ $200.41 Million USD

Based on the latest financial reports, Kolon Life Science Inc (102940) has total liabilities worth ₩295.72 Billion KRW (≈ $200.41 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Kolon Life Science Inc equity growth rate to track the company's year-over-year net asset growth rate.

Kolon Life Science Inc - Total Liabilities Trend (2014–2024)

This chart illustrates how Kolon Life Science Inc's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Kolon Life Science Inc to measure how efficiently the company converts operating cash flow to free cash.

Kolon Life Science Inc Competitors by Total Liabilities

The table below lists competitors of Kolon Life Science Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Garuda Metalindo Tbk PT JK:BOLT	Indonesia	Rp581.39 Billion
FCR Immobilien AG XETRA:FC9	Germany	€277.95 Million
Samick Thk KO:004380	Korea	₩257.11 Billion
eWork Group AB ST:EWRK	Sweden	Skr2.76 Billion
Shinsegae I&C KO:035510	Korea	₩152.06 Billion
HB Technology CO.LTD KQ:078150	Korea	₩92.24 Billion
Affluent Medical SAS PA:AFME	France	€38.73 Million
Salasar Techno Engineering Limited NSE:SALASAR	India	Rs13.19 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Kolon Life Science Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 102940 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.56	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.85	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kolon Life Science Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kolon Life Science Inc (2014–2024)

The table below shows the annual total liabilities of Kolon Life Science Inc from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩270.23 Billion ≈ $183.13 Million	+57.32%
2023-12-31	₩171.76 Billion ≈ $116.40 Million	+17.33%
2022-12-31	₩146.39 Billion ≈ $99.21 Million	+8.24%
2021-12-31	₩135.25 Billion ≈ $91.66 Million	-28.96%
2020-12-31	₩190.38 Billion ≈ $129.02 Million	+7.39%
2019-12-31	₩177.27 Billion ≈ $120.14 Million	+2.61%
2018-12-31	₩172.76 Billion ≈ $117.08 Million	+0.80%
2017-12-31	₩171.38 Billion ≈ $116.14 Million	+80.81%
2016-12-31	₩94.78 Billion ≈ $64.23 Million	+1.73%
2015-12-31	₩93.17 Billion ≈ $63.14 Million	+28.13%
2014-12-31	₩72.72 Billion ≈ $49.28 Million	--

About Kolon Life Science Inc

KQ:102940 Korea Pharmaceuticals

Market Cap

$110.48 Million

₩163.02 Billion KRW

Market Cap Rank

#18756 Global

#838 in Korea

Share Price

₩14290.00

Change (1 day)

+7.44%

52-Week Range

₩13300.00 - ₩70800.00

All Time High

₩163572.85